Li,Shan, Wang,Xiaoman, Zhang,Jielei, Li,Jingyi, Liu,Xiaogang, Ma,Yuanyuan, . . . Zheng,Lili. (2018). Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease.
Chicago Style CitationLi,Shan, Wang,Xiaoman, Zhang,Jielei, Li,Jingyi, Liu,Xiaogang, Ma,Yuanyuan, Han,Chao, Zhang,Lixia, and Zheng,Lili. Exenatide Ameliorates Hepatic Steatosis and Attenuates Fat Mass and FTO Gene Expression Through PI3K Signaling Pathway in Nonalcoholic Fatty Liver Disease. 2018.
MLA CitationLi,Shan, et al. Exenatide Ameliorates Hepatic Steatosis and Attenuates Fat Mass and FTO Gene Expression Through PI3K Signaling Pathway in Nonalcoholic Fatty Liver Disease. 2018.
Note: citation formatting may not correspond 100% to that defined by the respective standard, to manage citations it is recommended to use the software Zotero
, which allows the automatic upload of Oasisbr references.